Revised version (INFD-D-20-00242): impact of 16S rDNA sequencing on clinical treatment decisions: a single center retrospective study

Revised version (INFD-D-20-00242): impact of 16S rDNA sequencing on clinical treatment decisions: a single center retrospective study

Abstract Background PCRs targeting 16S ribosomal DNA (16S PCR) followed by Sanger’s sequencing can identify bacteria from normally sterile sites and complement standard analyzes, but they are expensive. We conducted a retrospective study in the Strasbourg University Hospital to assess the clinical i...

Full description

Bibliographic Details
Main Authors: Axel Ursenbach, Frédéric Schramm, François Séverac, Yves Hansmann, Nicolas Lefebvre, Yvon Ruch, Xavier Argemi
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Infectious Diseases
Subjects:
16S PCR
Clinical significance
Polymerase chain reaction
Antibiotic therapy
Online Access:https://doi.org/10.1186/s12879-021-05892-4

Internet

https://doi.org/10.1186/s12879-021-05892-4

Similar Items